Pfizer is going to be making 5.7 billion dollars in revenue from Paxlovid at the bare minimum in the next 6 months, in the US. That's around as much revenue as

Pfizer is going to be making 5.7 billion dollars in revenue from Paxlovid at the bare minimum in the next 6 months, in the US. That's around as much revenue as 300 million vaccine doses. We are already past the tipping point, as of around 20 days ago.